Protagonist Therapeutics Inc. (PTGX) tumbled -7.51% or -0.65 to $8.0. It is approximately 60799 shares traded, which is 46.85% compare to the average total volume 129762. The market cap of PTGX is $192.68 million. The year to date change is -66.62%. The 52 week price range is from $5.5 to $23.97. Price of PTGX have changed -5.36% during last week. It have changed 0.46% over last month, 11.61% over last 3 months, -3.03% over last 6 months and -45.01% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTGX is 9.27. It is 15.88% above current price. The 200-day Moving Averages for PTGX is 11.37. It is 42.13% above current price. The 52-week High is 23.97. It is 199.62% from the current price. The 52-week Low is 5.5. It is -31.25% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of PTGX is 1.95 on 2018-09-28. Short % to float is 1.20%. There are some statistics of PTGX. It is has market cap $192.68 million. The share outstanding is 24.09 million. The average volume is 129762. The revenue is 8.78M. The percent of top 15 Institution holding is 69.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTGX is -28.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTGX is -23.10%.